| Record ID | marc_loc_updates/v39.i48.records.utf8:3476886:1046 |
| Source | Library of Congress |
| Download Link | /show-records/marc_loc_updates/v39.i48.records.utf8:3476886:1046?format=raw |
LEADER: 01046cam a2200325 a 4500
001 2009934340
003 DLC
005 20111123121654.0
008 090806s2009 ne ac b 001 0 eng c
010 $a 2009934340
016 7 $a101520162$2DNLM
020 $a9781607500551
020 $a1607500558
035 $a(OCoLC)ocn441170769
040 $aNLM$cNLM$dBTCTA$dDLC
042 $apcc
050 00 $aQP99.3.P7$bR35 2009
060 00 $aW1$bPH178R v.11 no.4 2009
060 10 $aWH 400$bR221 2009
245 00 $aRare diseases :$bfocus on rare plasma related disorders /$ceditor, J.L. Valverde.
260 $aAmsterdam :$bIOS Press,$c2009.
300 $avi, 235-563 p. :$bill., port.
490 1 $aPharmaceuticals policy and law,$x1389-2827 ;$vv. 11(4)
504 $aIncludes bibliographical references and index.
650 0 $aBlood proteins$xTherapeutic use.
650 0 $aRare diseases.
650 12 $aPlasma.
650 22 $aRare Diseases.
700 1 $aValverde, José Luis.
830 0 $aPharmaceuticals policy and law ;$vv. 11, no. 4.$x1389-2827